Literature DB >> 20368882

Recurrent renal cell cancer: 10 years or more after nephrectomy.

Emmanuel Abara1, Iolanda Chivulescu, Nilam Clerk, Pablo Cano, Alexis Goth.   

Abstract

Localized renal cell carcinoma (RCC) responds well to surgery. Patients often question how long they have to be on surveillance after their surgery. Several follow-up patterns have been described in the literature. Until 2009, no published established Canadian guidelines existed to assist Canadian health-care practitioners in the surveillance of these patients. We present 3 cases of RCC that recurred 10 years or longer after the initial nephrectomy. These cases emphasize the need for careful long-term follow-up, as recommended in the Canadian Urological Association guidelines. We also discuss the optimism of prolonged disease survival in the era of novel therapeutic agents that target angiogenesis.

Entities:  

Year:  2010        PMID: 20368882      PMCID: PMC2845671          DOI: 10.5489/cuaj.829

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  17 in total

Review 1.  Single cerebral metastasis 3 and 19 years after primary renal cell carcinoma: case report and review of the literature.

Authors:  F Roser; S K Rosahl; M Samii
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Sunitinib, sorafenib and other systemic noncytotoxic kidney cancer therapies can and should be administered by urologists.

Authors:  Laurence Klotz
Journal:  Can Urol Assoc J       Date:  2007-06       Impact factor: 1.862

3.  Follow-up guidelines after radical or partial nephrectomy for localized and locally advanced renal cell carcinoma.

Authors:  Wassim Kassouf; Robert Siemens; Christopher Morash; Louis Lacombe; Michael Jewett; Larry Goldenberg; Joseph Chin; Michael Chetner; Christopher G Wood; Simon Tanguay; Armen G Aprikian
Journal:  Can Urol Assoc J       Date:  2009-02       Impact factor: 1.862

4.  Patterns of tumor recurrence and guidelines for followup after nephron sparing surgery for sporadic renal cell carcinoma.

Authors:  K S Hafez; A C Novick; S C Campbell
Journal:  J Urol       Date:  1997-06       Impact factor: 7.450

5.  Renal cell carcinoma guideline.

Authors:  Börje Ljungberg; Damian C Hanbury; Marcus A Kuczyk; Axel S Merseburger; Peter F A Mulders; Jean-Jacques Patard; Ioanel C Sinescu
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

Review 6.  Follow-up after partial or total nephrectomy for renal cell carcinoma.

Authors:  J E Montie
Journal:  Urol Clin North Am       Date:  1994-11       Impact factor: 2.241

7.  Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.

Authors:  Andrew J Stephenson; Michael P Chetner; Keith Rourke; Martin E Gleave; M Signaevsky; Bruce Palmer; James Kuan; Gerald B Brock; Simon Tanguay
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

Review 8.  Molecular targeting agents in renal cell carcinoma: present strategies and future perspectives.

Authors:  Snezana K Bjelogrlic; Sinisa Radulovic; Nada Babovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

9.  Pre-treatment global quality of health predicts progression free survival in metastatic kidney cancer patients treated with sorafenib or sunitinib.

Authors:  Edwin Herrmann; Joachim Gerss; Stefan Bierer; Thomas Köpke; Christian Bolenz; Lothar Hertle; Christian Wülfing
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-01       Impact factor: 4.553

10.  Solitary liver metastasis of chromophobe renal cell carcinoma 20 years after nephrectomy treated by hepatic resection.

Authors:  Jeffrey T Lordan; William J Fawcett; Nariman D Karanjia
Journal:  Urology       Date:  2008-03-10       Impact factor: 2.649

View more
  6 in total

1.  Renal cell carcinoma metastasis to the ciliary body responds to proton beam radiotherapy: a case report.

Authors:  Tarek Alasil; Bahram Khazai; Lilia Loredo; Michael E Rauser
Journal:  J Med Case Rep       Date:  2011-08-03

Review 2.  Current Challenges in Diagnosis and Assessment of the Response of Locally Advanced and Metastatic Renal Cell Carcinoma.

Authors:  Alberto Diaz de Leon; Ali Pirasteh; Daniel N Costa; Payal Kapur; Hans Hammers; James Brugarolas; Ivan Pedrosa
Journal:  Radiographics       Date:  2019-06-14       Impact factor: 5.333

3.  Images - A nose metastasis heralding renal cell carcinoma recurrence 25 years post-nephrectomy.

Authors:  Jesse Spooner; Manjot Birk; Davide Salina; Nathan Hoag
Journal:  Can Urol Assoc J       Date:  2019-09-27       Impact factor: 1.862

4.  A Rare Case of Metastasis of Renal Clear Cell Carcinoma to the Thyroid Gland, Presenting as a Goiter Nodule, Three Years After Nephrectomy.

Authors:  Hedieh Moradi Tabriz; Arezoo Eftekhar Javadi; Atieh Zandnejadi
Journal:  Iran J Pathol       Date:  2020-07-16

5.  Promising pharmacological profile of a Kunitz-type inhibitor in murine renal cell carcinoma model.

Authors:  Jean Gabriel de Souza; Katia L.P. Morais; Eduardo Anglés-Cano; Pamela Boufleur; Evandro Sobroza de Mello; Durvanei Augusto Maria; Clarice Silvia Taemi Origassa; Hamilton de Campos Zampolli; Niels Olsen Saraiva Câmara; Carolina Maria Berra; Rosemary Viola Bosch; Ana Marisa Chudzinski-Tavassi
Journal:  Oncotarget       Date:  2016-09-20

6.  Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: a case report.

Authors:  Mustufa Babar; Saad Hamdani; Corinne Liu; Jogarao Vedula; David S Schnapp
Journal:  BMC Urol       Date:  2019-12-27       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.